Details for New Drug Application (NDA): 012164
✉ Email this page to a colleague
NDA 012164 describes NATURETIN-5, which is a drug marketed by Apothecon and is included in one NDA. Additional details are available on the NATURETIN-5 profile page.
The generic ingredient in NATURETIN-5 is bendroflumethiazide. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide profile page.
The generic ingredient in NATURETIN-5 is bendroflumethiazide. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide profile page.
Summary for 012164
| Tradename: | NATURETIN-5 |
| Applicant: | Apothecon |
| Ingredient: | bendroflumethiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012164
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
